Sherman M. Chin

3.5k total citations · 1 hit paper
14 papers, 2.0k citations indexed

About

Sherman M. Chin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sherman M. Chin has authored 14 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Sherman M. Chin's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Sherman M. Chin is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Sherman M. Chin collaborates with scholars based in United States, Netherlands and Israel. Sherman M. Chin's co-authors include Stuart Linn, James A. Imlay, Yongzhang Luo, Arvind Rajpal, Javier Chaparro‐Riggers, Yik A. Yeung, Kevin C. Lindquist, Yasmina Abdiche, Pavel Strop and Amber Pham and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Sherman M. Chin

14 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxic DNA Damage by Hydrogen Peroxide Through the Fenton Reaction in Vivo and in Vitro

1988 1.3k citations James A. Imlay, Sherman M. Chin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherman M. Chin United States	12	828	325	231	220	191	14	2.0k
Yan‐Ming Xu China	29	1.6k 2.0×	341 1.0×	368 1.6×	154 0.7×	133 0.7×	140	2.9k
Sanetaka Shirahata Japan	25	906 1.1×	331 1.0×	141 0.6×	281 1.3×	127 0.7×	166	2.6k
Richard C. Zangar United States	29	1.2k 1.4×	170 0.5×	307 1.3×	210 1.0×	73 0.4×	74	2.5k
C C Winterbourn New Zealand	24	970 1.2×	556 1.7×	331 1.4×	173 0.8×	70 0.4×	32	2.9k
Gulam Waris United States	16	1.0k 1.3×	330 1.0×	294 1.3×	53 0.2×	104 0.5×	19	2.7k
Per Hägglund Denmark	31	1.6k 1.9×	216 0.7×	142 0.6×	141 0.6×	139 0.7×	106	2.8k
Yushi Liu China	27	837 1.0×	178 0.5×	196 0.8×	116 0.5×	125 0.7×	100	1.9k
Yinan Wei United States	24	1.3k 1.6×	196 0.6×	127 0.5×	104 0.5×	177 0.9×	91	2.2k
Paulo Filipe Portugal	29	538 0.6×	469 1.4×	172 0.7×	75 0.3×	68 0.4×	217	2.8k
Arthur J. Wittwer United States	30	1.1k 1.3×	340 1.0×	279 1.2×	130 0.6×	103 0.5×	51	2.3k

Countries citing papers authored by Sherman M. Chin

Since Specialization

Citations

This map shows the geographic impact of Sherman M. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherman M. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherman M. Chin more than expected).

Fields of papers citing papers by Sherman M. Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherman M. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherman M. Chin. The network helps show where Sherman M. Chin may publish in the future.

Co-authorship network of co-authors of Sherman M. Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Sherman M. Chin. A scholar is included among the top collaborators of Sherman M. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherman M. Chin. Sherman M. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Moynihan, Kelly D., Manu P. Kumar, Hussein Sultan, et al.. (2024). IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity. Cancer Discovery. 14(7). 1206–1225. 27 indexed citations

Andreata, Francesco, Kelly D. Moynihan, Valeria Fumagalli, et al.. (2024). CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus. Science Translational Medicine. 16(729). eadi1572–eadi1572. 14 indexed citations

Al-Khami, Amir A., Sawsan Youssef, Yasmina Abdiche, et al.. (2020). Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody. Molecular Cancer Therapeutics. 19(10). 2105–2116. 11 indexed citations

Yeung, Yik A., Veena Krishnamoorthy, Cesar Sommer, et al.. (2020). An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity. Molecular Therapy. 28(3). 889–900. 26 indexed citations

Chin, Sherman M., Christopher R. Kimberlin, Zygy Roe-Žurž, et al.. (2018). Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab. Nature Communications. 9(1). 4679–4679. 95 indexed citations

Youssef, Sawsan, Yasmina Abdiche, HoangKim Nguyen, et al.. (2017). Abstract 2667: In vitro properties and pre-clinical activity of PF-06801591, a high-affinity engineered anti-human PD-1. Cancer Research. 77(13_Supplement). 2667–2667. 3 indexed citations

Abdiche, Yasmina, Yik A. Yeung, Javier Chaparro‐Riggers, et al.. (2015). The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity. mAbs. 7(2). 331–343. 154 indexed citations

Lee, Li‐Fen, Kathryn Logronio, Guang Huan Tu, et al.. (2012). Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proceedings of the National Academy of Sciences. 109(31). 12674–12679. 110 indexed citations

Hong, Liang, Javier Chaparro‐Riggers, Pavel Strop, et al.. (2011). Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 340(2). 228–236. 90 indexed citations

10.

Luo, Yongzhang, et al.. (1994). Three chemically distinct types of oxidants formed by iron-mediated Fenton reactions in the presence of DNA.. Proceedings of the National Academy of Sciences. 91(26). 12438–12442. 119 indexed citations

11.

Malcolm, Bruce A., Sherman M. Chin, David A. Jewell, et al.. (1992). Expression and characterization of recombinant hepatitis A virus 3C proteinase. Biochemistry. 31(13). 3358–3363. 50 indexed citations

12.

Haigwood, Nancy L., Lynda Misher, Sherman M. Chin, et al.. (1992). Characterization of group specific antibodies in primates: Studies with SIV envelope in macaques. Journal of Medical Primatology. 21(2-3). 82–90. 11 indexed citations

13.

Linn, Stuart, Sherman M. Chin, & James A. Imlay. (1989). Killing, Stress Responses and Mutagenesis Induced in E. Coli by Hydrogen Peroxide. 373–376. 1 indexed citations

14.

Imlay, James A., Sherman M. Chin, & Stuart Linn. (1988). Toxic DNA Damage by Hydrogen Peroxide Through the Fenton Reaction in Vivo and in Vitro. Science. 240(4852). 640–642. 1287 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact